These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas. Ishiguro N, Matsui T, Shinagawa M. Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930 [Abstract] [Full Text] [Related]
3. Neurofibromatosis. A genetic epidemiologist's point of view. Mulvihill JJ. Ann N Y Acad Sci; 1986 Dec; 486():38-44. PubMed ID: 3105401 [No Abstract] [Full Text] [Related]
4. Evidence against linkage of von Recklinghausen neurofibromatosis and chromosome 19 markers. Huson SM, Meredith AL, Sarfarazi M, Shaw DJ, Brook D, Compston DA, Harper PS. Ann N Y Acad Sci; 1986 Dec; 486():349-53. PubMed ID: 3105398 [Abstract] [Full Text] [Related]
12. Expression of cellular oncogenes in primary cells from human acute leukemias. Mavilio F, Sposi NM, Petrini M, Bottero L, Marinucci M, De Rossi G, Amadori S, Mandelli F, Peschle C. Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570 [Abstract] [Full Text] [Related]
13. Linkage analysis between the beta-nerve growth factor gene and other chromosome lp markers and disseminated neurofibromatosis. Darby JK, Goslin K, Riccardi VM, Huson SM, Ferrell R, Kidd J, Seizinger BR, Ferrier J, Shooter EM, Cavalli-Sforza LL. Ann N Y Acad Sci; 1986 Jun; 486():311-26. PubMed ID: 2882715 [No Abstract] [Full Text] [Related]
14. [Characteristic skin markers as the leading symptom of selected dysplasia syndromes with neurocutaneous manifestations]. Menzel K, Walch R, Schulze F, Langelotz A. Padiatr Grenzgeb; 1987 Jun; 26(4):239-46. PubMed ID: 3116486 [No Abstract] [Full Text] [Related]
15. The genetic aspects of neurofibromatosis. Carey JC, Baty BJ, Johnson JP, Morrison T, Skolnick M, Kivlin J. Ann N Y Acad Sci; 1986 Jun; 486():45-56. PubMed ID: 3105404 [Abstract] [Full Text] [Related]